Health
Johnson & Johnson starts human study of COVID-19 vaccine after promising monkey data – Reuters India
Johnson & Johnson on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.
(Reuters) – Johnson & Johnson on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.
When exposed to the virus, six out of six animals who got the vaccine candidate were completely protected from lung disease and five out of six were protected from infection as measured by the presence of virus in nasal swabs, according to the study p…
-
Noosa News23 hours agoNorth Lakes home erupts in flames as woman rushed from burning house with injuries
-
Noosa News23 hours agoChild safety boss says Unify IT system was launched for budgetary reasons
-
Noosa News23 hours agoBroncos respond to Storm star Stefano Utoikamanu’s ‘stuck up’ barb ahead of NRL grand final
-
Noosa News6 hours agoMan arrested following alleged armed rape and kidnapping in Maroochydore